Freeline Therapeutics Holdings (FRLN) Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201 Oct 4, 2023 07:00AM
Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease Oct 4, 2023 07:00AM
Freeline Reports Second Quarter 2023 Financial Results and Business Highlights Aug 15, 2023 07:00AM
Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call Aug 8, 2023 07:30AM
Freeline to Participate in Upcoming Investor Conferences Jul 31, 2023 07:30AM


Jul 25, 2023 07:30AM Freeline to Host Virtual KOL Event on its Gene Therapy Candidate, FLT201, in Gaucher Disease
Jun 26, 2023 07:30AM Freeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson’s Disease
Jun 2, 2023 08:00AM Freeline to Present at 2023 Jefferies Healthcare Conference
May 30, 2023 07:30AM Freeline Reports First Quarter 2023 Financial Results and Business Highlights
May 22, 2023 08:00AM Freeline Granted ILAP Designation in United Kingdom by MHRA for FLT201, an Investigational Gene Therapy for the Treatment of Gaucher Disease
May 12, 2023 08:05AM Freeline Therapeutics Holdings (FRLN) Announces ADS Ratio Change to 1:15
May 12, 2023 08:05AM Freeline Completes ADS Ratio Change
Apr 21, 2023 07:01AM Freeline Therapeutics Holdings (FRLN) Announces Proposed ADS Ratio Change
Apr 21, 2023 07:00AM Freeline Announces Proposed ADS Ratio Change
Apr 12, 2023 08:00AM Freeline to Present at 22nd Annual Needham Virtual Healthcare Conference
Mar 28, 2023 07:00AM Freeline Therapeutics to Host Full Year 2022 Financial Results Call
Feb 10, 2023 07:00AM Freeline Announces Closing of Sale of Its CMC-Focused German Subsidiary
Feb 2, 2023 04:30PM Freeline Reports January 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 19, 2023 08:01AM Freeline Publishes Preclinical Proof-of-Concept Data for FLT190, its AAV Gene Therapy Candidate for Fabry Disease, in the Nature Journal Gene Therapy
Apr 17, 2022 05:00AM World Hemophilia Day 2022 - "Access for All: Partnership. Policy. Progress. Engaging your government, integrating inherited bleeding disorders into national policy"
Feb 1, 2022 07:00AM AVROBIO Announces the Appointment of Sean O’Bryan as Chief Regulatory Officer
Aug 24, 2021 02:00AM PureTech Health plc – Half-Year Report
Aug 13, 2021 07:00AM PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer
May 11, 2021 05:00AM Tubulis Appoints Christian Grøndahl as Independent Chairman to Lead Supervisory Board
Aug 14, 2020 11:40AM Citi Appointed as Depositary Bank for Freeline’s ADR Programme